Endologix, Inc. (ELGX) CEO John Onopchenko on Q1 2020 Results - Earnings Call Transcript

May 13, 2020 3:29 PM ETEndologix, Inc. (ELGX)
SA Transcripts profile picture
SA Transcripts
133.66K Followers

Endologix, Inc. (NASDAQ:ELGX) Q1 2020 Results Conference Call May 11, 2020 4:30 PM ET

Company Participants

John Onopchenko - CEO

Vaseem Mahboob - CFO

Matthew Thompson - Chief Medical Officer

Conference Call Participants

Mathew Blackman - Stifel

Marie Thibault - BTIG

Allen Gong - JP Morgan

Operator

Greetings, and welcome to the Endologix First Quarter 2020 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the former presentation. [Operator Instructions] As a reminder, this conference call is being recorded. This conference call is also being broadcast live over the Internet at the Investors section of the company's website at www.endologix.com, and the webcast replay of the call will be available at the same site approximately 1 hour after the end of today's call.

Before we begin, I'd like to caution listeners that comments made by management during this conference call will include forward-looking statements within the meaning of federal securities laws. These forward-looking statements reflect management's expectations about future events, milestones and results of operations, including the impact of COVID-19 pandemic on the company's operations, anticipated regulatory approvals, clinical trial status, product portfolio updates and financial and operating projections and plans.

There are known and unknown risks, uncertainties and other factors that may cause the company's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. For a discussion of risk factors, the company encourages you to review its most annual report on Form 10-K, quarterly reports on Form 10-Q and subsequent reports as filed by the company with the Securities and Exchange Commission.

Furthermore, the content of this conference call contains time-sensitive information that is accurate only as of the date of the live broadcast, May 11, 2020. Endologix undertakes no

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.